<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cerebral sequential scintigraphy enables a process to be described according to its hemodynamics (Stage I), its degree of vascularization (Stage II), and the extent of the localized disturbance of the blood-brain barrier function (Stage III) </plain></SENT>
<SENT sid="1" pm="."><plain>For a given lesion, typical scintigraphic behaviour patterns can be described </plain></SENT>
<SENT sid="2" pm="."><plain>This report presents the results of a prospective series with 1722 patients examined using this method </plain></SENT>
<SENT sid="3" pm="."><plain>The accuracy of the different scintigraphic diagnoses, according to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type, was: <z:hpo ids='HP_0001297'>cerebrovascular accident</z:hpo> with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> - 92% (= <z:chebi fb="4" ids="46274">CVA</z:chebi>), <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> - 90%, bone or meningital process - 89%, malignant <z:hpo ids='HP_0009733'>glioma</z:hpo> - 91%, <z:hpo ids='HP_0002858'>meningioma</z:hpo> - 74%, highly differentiated <z:hpo ids='HP_0009733'>glioma</z:hpo> - 67%, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0100309'>subdural hematoma</z:hpo> - 54%, A-V <z:mp ids='MP_0002947'>angioma</z:mp> - 54%, brain <z:mpath ids='MPATH_612'>abscess</z:mpath> - 45% </plain></SENT>
<SENT sid="4" pm="."><plain>The differential diagnosis between <z:mp ids='MP_0009277'>brain tumor</z:mp> and <z:chebi fb="4" ids="46274">CVA</z:chebi> with infarction was possible in approximately 97% of the patients, the differential diagnosis of intracranial space-occupying lesion versus <z:chebi fb="4" ids="46274">CVA</z:chebi> with infarction in approximately 95% </plain></SENT>
<SENT sid="5" pm="."><plain>There were 14 false positive results recorded (0.8% of the 1722 patients) </plain></SENT>
</text></document>